At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.
We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.
What You’ll Do:
We are seeking an experienced Data Management leader to join us as the Senior Director, Data Management. Reporting to VP, head of Biometrics, this role will define and execute the global clinical data management strategy, scale the data infrastructure, and oversee end-to-end data integrity across all phases of clinical development. As a strategic and operational leader, this individual will drive data quality, standardize processes, and ensure inspection readiness.
Responsibilities:
- Actively plan and manage full-lifecycle clinical data quality and integrity across all trials (including eCRF builds, edit checks, external data integrations, reconciliations, data cleaning, database locks, and submission readiness).
- Build and scale a high-performing Data Management organization; drive departmental performance, resource allocation, and talent development to maintain a resilient, growth-oriented team.
- Drive strict compliance with global regulatory standards and internal SOPs while supporting regulatory audits and maintaining inspection readiness.
- Cultivate strong cross-functional partnerships and represent Data Management in key cross-functional forums and enterprise initiatives.
- Manage CRO relationships to ensure timely, high-quality deliverables, establishing robust quality metrics and governance frameworks.
Required Qualifications:
- 10+ years of clinical data management experience within the pharmaceutical or biotechnology industry, including 5+ years in a people-management role.
- Experience with large clinical trial data sets
- Proven track record of providing strategic data management leadership across late-stage development programs, ensuring data integrity, data quality, and inspection readiness.
- Proven track record of leading Data Management activities through successful global health authority filings (NDA, BLA, or MAA) and health authority interactions. .
- Expert knowledge of clinical trial data management, CDASH standards, database lock execution, external data reconciliation (eCOA, central labs, PK, etc.), inspection readiness, and strict adherence to regulatory guidelines (e.g., ICH, GCP) and internal SOPs.
- Proven ability to build, mentor, and retain high-performing teams while driving a culture of continuous improvement, accountability, and operational excellence.
- Deep expertise in global CRO oversight, vendor management, and strategic outsourcing models to ensure high-quality deliverables, timeline adherence, and cost control.
Preferred Qualifications:
- Experience in cardiometabolic disease areas preferred
Education:
- Advanced degree (Master) in Life Sciences, Statistics, Data Science, or a related quantitative field.
For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.
EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:
Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.
E-Verify:
Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.
#LI-Hybrid
Skills Required
- 10+ years of clinical data management experience within the pharmaceutical or biotechnology industry
- 5+ years of experience in a people-management role
- Experience with large clinical trial data sets
- Strategic data management leadership across late-stage development programs
- Experience ensuring data integrity, data quality, and inspection readiness
- Experience leading Data Management activities through global health authority filings, including NDA, BLA, or MAA submissions
- Experience with health authority interactions
- Expert knowledge of clinical trial data management and CDASH standards
- Experience with database lock execution and external data reconciliation, including eCOA, central labs, and PK data
- Knowledge of inspection readiness, ICH, GCP, and internal SOP compliance
- Ability to build, mentor, and retain high-performing teams
- Expertise in global CRO oversight, vendor management, and strategic outsourcing models
- Advanced degree in Life Sciences, Statistics, Data Science, or a related quantitative field
- Experience in cardiometabolic disease areas
What We Do
Kailera is an advanced clinical-stage biotechnology company focused on obesity care. It is developing a diversified pipeline of GLP-1 therapies and other obesity-management medications intended to provide treatment options for people living with obesity across their treatment journeys. The company’s team has experience developing and commercializing therapies for metabolic diseases, and its clinical-stage candidates use multiple GLP-1 mechanisms and routes of administration.
